Cardiac Assist Devices Market Size Report 2030 | DelveInsight

DelveInsight's Cardiac Assist Devices Market Insights Report 2030 provides the current and forecast market analysis, individual leading companies market shares, challenges, Market Drivers, barriers, trends, and key market Cardiac Assist Devices Companies in the market.

To read more about the latest highlights related to the Cardiac Assist Devices Market, get a snapshot of the key highlights entailed in the Market Report @ Cardiac Assist Devices Market Size- https://www.delveinsight.com/sample-request/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Cardiac Assist Devices Market Report
• The Cardiac Assist Devices Market was valued at USD 2.89 billion in 2023, growing at a CAGR of 13.70% during the forecast period from 2024 to 2030, to reach USD 6.23 billion by 2030.
• North America is expected to hold the largest share of the Cardiac Assist Devices organization market in 2023, driven by several key factors.
• The leading Cardiac Assist Devices Companies such as Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, BrioHealth Solutions, Inc., BiVACOR, Inc., Magenta Medical, Abiomed, SynCardia, and others.

To know more about why North America is leading the market growth in the Bi Cardiac Assist Devices Market, get a snapshot @ Cardiac Assist Devices Market Outlook- https://www.delveinsight.com/sample-request/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cardiac Assist Devices Market Dynamics
According to the latest data published by the British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, live with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021. Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, the most commonly diagnosed worldwide, affects an estimated 200 million people globally. Approximately 110 million men and 80 million women are affected. Additionally, around 56 million women and 45 million men are stroke survivors. It is estimated that at least 13 million people worldwide live with congenital heart disease, with potentially millions more undiagnosed.

Cardiac Assist Devices Market Segment Analysis
Cardiac Assist Devices Market by Product (Ventricular Assist Devices [Left Ventricular Assist Devices (LVAD), Biventricular Ventricular Assist Devices (BIVAD), and Right Ventricular Assist Devices (RVAD)], Artificial Heart, and Intra-Aortic Balloon Pump), Type (Transcutaneous and Implantable), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, and Bridge-To-Candidacy (BTC Therapy), End-User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get a sneak peek at the Cardiac Assist Devices Market Dynamics @ Cardiac Assist Devices Market Dynamics Analysis- https://www.delveinsight.com/sample-request/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cardiac Assist Devices Companies
Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, BrioHealth Solutions, Inc., BiVACOR, Inc., Magenta Medical, Abiomed, SynCardia, and others.

Cardiac Assist Devices Market Drivers
The demand for cardiac assist devices is motivated by a rise in the prevalence of cardiovascular diseases such as heart failure, coronary artery disease, and others globally which has led to an increased need for these devices. Additionally, the scarcity of heart donors further intensifies this demand, as the limited availability of donor organs leads to longer waiting times for transplantation, pushing patients and healthcare providers to seek alternative solutions such as cardiac assist devices. Concurrently, increasing awareness and screening programs contribute to early detection and diagnosis of cardiovascular conditions, leading to higher patient referrals and a greater need for such assistive technologies. Moreover, the market is fueled by a surge in product launches and regulatory approvals from key market players, which introduces more advanced and effective cardiac assist devices to the market. This influx of new products enhances treatment options and competition among manufacturers, driving further innovation and improvements in device technology during the forecast period from 2024 to 2030.

Which MedTech key players in the Cardiac Assist Devices Market are set to emerge as the trendsetter explore @ Cardiac Assist Devices Companies- https://www.delveinsight.com/sample-request/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Cardiac Assist Devices Market Report
• Coverage- Global
• Forecast Period- 2024-2030
• Cardiac Assist Devices Companies- Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, BrioHealth Solutions, Inc., BiVACOR, Inc., Magenta Medical, Abiomed, SynCardia, and others.

Interested in knowing the Cardiac Assist Devices Market by 2030? Click to get a snapshot of the Cardiac Assist Devices Market Trends- https://www.delveinsight.com/sample-request/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.